United States - English - NLM (National Library of Medicine)

sun pharmaceutical industries, inc. - tramadol hydrochloride (unii: 9n7r477wck) (tramadol - unii:39j1lgj30j) - tramadol hydrochloride extended-release tablets are indicated for the management of severe and persistent pain  that requires an extended treatment period with a daily opioid analgesic and for which alternative treatment options are inadequate. limitations of use - because of the risks of addiction, abuse, and misuse, with opioids, which can occur at any dosages or duration, and because of the greater risks of overdose and death with extended-release/long-acting opioid formulations [see warnings] , reserve tramadol hydrochloride extended-release tablets for use in patients for whom alternative treatment options (e.g., non-opioid analgesics or immediate-release opioids) are ineffective, not tolerated, or would be otherwise inadequate to provide sufficient management of pain. - tramadol hydrochloride extended-release tablets are not indicated as an as-needed (prn) analgesic. tramadol hydrochloride extended-release tablets are contraindicated for: - all children younger than 12 years of age [see warnings ]. - postoperative management in children younger than 18 years of age following tonsillectomy and/or adenoidectomy [see warnings ]. tramadol hydrochloride extended-release tablets are also contraindicated in patients with: - significant respiratory depression [see warnings ] - acute or severe bronchial asthma in an unmonitored setting or in the absence of resuscitative equipment [see warnings ] - known or suspected gastrointestinal obstruction, including paralytic ileus [see warnings ] - hypersensitivity to tramadol (e.g., anaphylaxis) [see adverse reactions ] - concurrent use of monoamine oxidase inhibitors (maois) or use within the last 14 days [see precautions; drug interactions ]

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

eco animal health europe ltd. - ivermectin 18,7 mg/g - oral paste - 18,7 mg/g - ivermectin 18.7 mg/g - ivermectin - horse

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

zoetis belgium sa-nv - moxidectine 18,92 mg/g - oral gel - 18,92 mg/g - moxidectin 18.92 mg/g - moxidectin - horse

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

boehringer ingelheim animal health belgium sa-nv - ivermectin 18,7 mg/g - oral paste - 18,7 mg/g - ivermectin 18.7 mg/ml - ivermectin - horse

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

boehringer ingelheim animal health belgium sa-nv - ivermectin 18,7 mg/g - oral paste - 18,7 mg/g - ivermectin 18.7 mg/g - ivermectin - horse

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

eco animal health europe ltd. - ivermectin 18,7 mg/g - oral paste - 18,7 mg/g - ivermectin 18.7 mg/g - ivermectin - horse

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

bimeda animal health ltd. - ivermectin 18,7 mg/g - oral paste - 18,7 mg/g - ivermectin 18.7 mg/g - ivermectin - horse

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

eco animal health europe ltd. - ivermectin 18,7 mg/g - oral paste - 18,7 mg/g - ivermectin 18.7 mg/g - ivermectin - horse

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

norbrook laboratories (ireland) ltd. - ivermectin 18,7 mg/g - oral paste - 18,7 mg/g - ivermectin 18.7 mg/g - ivermectin - horse

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

norbrook laboratories (ireland) ltd. - praziquantel 140,3 mg/g; ivermectin 18,7 mg/g - oral paste - 18,7 mg/g - 140,3 mg/g - ivermectin 18.7 mg/g; praziquantel 140.3 mg/g - ivermectin, combinations - horse